Tag Archives: CTIC FDA Panel

No Light at The End of Tunnel

Posted on March 22, 2010 by admin

Cell Therapeutics (CTIC.O) suffered a setback on Monday as a U.S. advisory panel said the company had not collected enough data to win clearance for an experimental lymphoma drug. Today was the doom day for may CTIC  investors.  Two decade … Continue reading →

Posted in Biotech Stock | Tagged , , , , | 1 Comment